AVIR

Atea Pharmaceuticals, Inc. Common Stock
Data: 2026-01-30
$4.24
Price
9.72%
Change
$4.3399
52W High
$2.455
52W Low

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Quick Stats
Jan 30, 2026

59.0

AI Score

HOLD

2.77

Volume Ratio

Mar 05, 2026

Next Earnings

17

+ve Days (30d)

12

-ve Days (30d)

AVIR Stock Summary

Last updated Jan 30, 2026

AVIR is currently trading at $4.24, positioned above its 200-day moving average of $3.26, indicating a long-term uptrend. The stock has a 52-week range of $2.455 to $4.3399.

Technical Analysis: The 50-day moving average stands at $3.38, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 68.664, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.241, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates AVIR at 59.0/100 with a HOLD recommendation.

AVIR (Atea Pharmaceuticals, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 68.664
CMF (20) 0.241
ROC (10) 23.256
ADX (14) 38.222
Indicator Value
MACD (12,26,9) 0.184
AROONOSC (14) 21.429
WILLAMS %R (14) -9.991
MFI (14) 61.081
AVIR Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

AVIR Price vs Max Options Open Interest
AVIR Max Change In Options Open Interest

AVIR Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

AVIR Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

AVIR Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

AVIR Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Atea Pharmaceuticals, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.

AVIR Moving Averages Analysis

Atea Pharmaceuticals, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

Atea Pharmaceuticals, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026

AVIR (Atea Pharmaceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 3.83
20 3.66
30 3.58
50 3.38
100 3.24
200 3.26

AVIR Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 331.3 million
Earnings/Share ($) -1.77
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.725
EPS Estimate Next Year ($) -1.745
WallStreet Target Price ($) 7.6667
Most Recent Quarter